Canntab Therapeutics building cannabis delivery facility with FSD Pharma

Canntab Therapeutics Ltd (CSE:PILL) CEO Jeff Renwick and CFO Richard Goldstein tell Proactive Investor’s Christine Corrado the cannabis delivery manufacturing company is lining up its ducks ahead of the legalization of cannabis in Canada on October 17 this year – as it announced a profit sharing collaboration with medical pot producer FSD Pharma Inc.

Canntab will build, at its own expense, its own manufacturing facility to produce cannabis oral dose delivery platforms.